HKEX to roll out new weekly options, biotech futures amid trading boom



Hong Kong Exchanges and Clearing (HKEX) will launch five new weekly stock options and a Hang Seng Biotech Index Futures contract this month, expanding hedging tools for investors as derivatives trading on the bourse hits record levels, a senior executive said.

The new weekly stock options – tracking CNOOC, China Mobile, AIA Group, Xiaomi and Semiconductor Manufacturing International Corporation (SMIC) – will begin trading on November 10, while the biotech futures contract will debut on November 28.

HKEX’s average daily turnover of equity-derivative contracts rose 7 per cent year on year to 1.54 million in the first nine months of 2025, putting the exchange on track for a third straight record year, according to exchange data.

“The active trading and the introduction of these new products underscore the market’s vibrancy and regional influence of the derivatives market in Hong Kong,” said HKEX senior vice-president David Lutz in a recent media briefing.

Hong Kong became the first Asian market to launch short-term weekly stock options in November 2024, starting with 10 major stocks including Tencent Holdings, HSBC and Alibaba Group Holding, which owns the Post.

Contemporary Amperex Technology Co (CATL) was added in June.

  • Related Posts

    China’s Top Numerical Control rides investor fervour for aerospace to 80% IPO gain

    Shares of Chinese aviation and aerospace parts supplier Shanghai Top Numerical Control Technology ended 80 per cent higher on its debut in Hong Kong on Wednesday, as investors continue to…

    Continue reading
    China’s private equity activity picks up as investors focus on tech and AI opportunities

    “In the last 12 to 18 months … we are seeing a lot more [private equity fundraising activities], but I would say it’s very selective” compared with the previous cycle,…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *